NTES: JP Morgan upgrades to Overweight, raises PT to $190 from $138.
JP Morgan has upgraded the rating for NTES to "Overweight" and raised the price target to $190 from $138, according to a recent announcement
FCX: JP Morgan Maintains Rating and Raises Price Target | FCX Stock News[1]. The upgrade reflects a significant increase in the stock's valuation, suggesting positive prospects for the company. The change in rating and price target comes amidst a broader trend of analysts revising their views on NTES.
Historically, NTES has seen a range of ratings and price targets from various analysts. On October 8, 2025, Wells Fargo initiated coverage on NTES with an "Overweight" rating and a price target of $140.00. Citigroup upgraded NTES to "Buy" from "Neutral" with a maintained price target of $145.00 on the same day. Morgan Stanley maintained an "Overweight" rating but lowered the price target to $135.00 from $140.00. UBS upgraded NTES to "Buy" from "Neutral" and raised the price target to $145.00 from $130.00. RBC Capital maintained a "Sector Perform" rating and lowered the price target to $145.00 from $150.00.
Based on the one-year price targets offered by 18 analysts, the average target price for NTES is $145.00 with a high estimate of $160.00 and a low estimate of $120.00. The average target implies an upside of 10.14% from the current price of $131.00. More detailed estimate data can be found on the NTES Forecast page.
The consensus recommendation from 19 brokerage firms is currently 2.5, indicating a "Hold" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
According to GuruFocus estimates, the estimated GF Value for NTES in one year is $150.00, suggesting an upside of 13.97% from the current price of $131.00. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at, calculated based on historical multiples and future estimates of business performance.
NTES operates in the technology sector and is known for its innovative products and services. The company's upgrade by JP Morgan signals a positive outlook for investors, though it is essential to consider the broader market conditions and the company's specific financial health.
Comments
No comments yet